KC-4848

293T-GRE-Luc2-ARV7 Cell Line

×
65953
Home » Cell Lines » 293T-GRE-Luc2-ARV7 Cell Line

Background of 293T-GRE-Luc2-ARV7 Cell Line

AR encodes androgen receptor and is also known as KD. The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes.

Specifications

Catalog NumberKC-4848
Cell Line Name293T-GRE-Luc2-ARV7 Cell Line
Clone Number4B2
Host Cell Line293T-GRE-Luc2
Description293T-GRE-Luc2-ARV7 is a stable reporter cell line for studying GRE, AR
QuantityOne vial of frozen cells (≥2×10⁶ cells/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10%FBS+150μg/mL Hygromycin B+1μg/mL Puromycin
Selection MarkerPuromycin, Hygromycin
MorphologyEpithelial
SubcultureSplit at a ratio of 1:4–1:6 every 2–3 days
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

293T-GRE-Luc2-ARV7 cell line was generated using a lentiviral vector expressing the GRE-Luc2-ARV7 reporter construct.

Characterization

Figure 1: Characterization of AR-V7 over-expression in the 293T-GRE-Luc2-ARV7 stable clone using Western Blot.

Figure 2: 293T-GRE-Luc2-ARV7 cell were seeded into 96-well plates, treated with AR-V7 degrader-1 in different concentrations for 16 hours, and then read out using Bright-Glo Detection System.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:4–1:6 every 2–3 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Vernooij MW, Oliveira TG, Wiest R et al. SWI versus T2*GRE for ARIA-H monitoring: a pragmatic perspective on adoption in clinical practice. Neuroradiology. 2026 Aug 31;:. PMID: 42671540. doi: 10.1007/s00234-026-04138-x.
  2. Zhang J, Zhang A, Tian J et al. Neutropenia events with androgen receptor pathway inhibitor-containing versus control therapies in prostate cancer patients: a systematic review and meta-analysis. BMC cancer. 2026 Aug 22;26(1):. PMID: 42864616. doi: 10.1186/s12885-026-16782-w.
  3. Tang MY, Chen TW, Zhang XM et al. GRE T2∗-weighted MRI: principles and clinical applications. BioMed research international. 2014;2014:312142. PMID: 24987676. doi: 10.1155/2014/312142.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.